How does human chorionic gonadotropin (hCG) rise throughout pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

hCG Rise Through Pregnancy

Human chorionic gonadotropin (hCG) rises rapidly in early pregnancy, peaking between 8-10 weeks of gestation (56-68 days), then declining to a nadir at 18 weeks, after which it remains relatively stable through the remainder of pregnancy without a secondary rise. 1

Early Pregnancy Pattern

Production and Detection:

  • Trophoblastic cells begin producing hCG as early as the 8-cell embryonic stage, with the blastocyst secreting detectable protein before implantation 2
  • Serum hCG becomes detectable (>5 mIU/mL, defining pregnancy) as early as 6 days after conception 3, 1
  • The hormone is detectable well before the first missed menstrual period

Rate of Rise: The early pregnancy rise follows a curvilinear pattern, not a simple linear progression 4. The doubling time varies by gestational age:

  • Early first trimester: hCG increases rapidly with characteristic doubling times
  • The rate of increase is not constant throughout early pregnancy—three distinct gestational periods exist, each with different linear increases when log-transformed 4
  • A uniform daily rise occurs when measured against accurate pregnancy dating methods 5

Peak and Decline Pattern

Peak Timing:

  • Maximum hCG levels occur between 56-68 days after conception (approximately 8-10 weeks gestational age) 1
  • Some patients with complete hydatidiform mole may show marked elevations >100,000 IU/L, though this represents pathology rather than normal pregnancy 6

Post-Peak Decline:

  • After peaking, hCG levels decline to a nadir at 18 weeks gestational age 1
  • This decline is physiologically normal and expected

Second and Third Trimester

Stable Plateau:

  • Following the 18-week nadir, hCG levels remain relatively stable throughout the remainder of pregnancy 1
  • No secondary rise occurs in the third trimester—earlier studies suggesting this were artifacts of non-specific immunoassays detecting cross-reacting substances 1
  • Modern beta-hCG radioimmunoassays confirm the absence of a late-pregnancy peak

Clinical Implications

First Trimester Physiology:

  • High hCG levels in early pregnancy cause physiologic TSH suppression, which can mimic hyperthyroidism but does not require treatment 7
  • The normal TSH range in the first trimester is reduced to 0.1-2.5 mIU/L due to hCG's thyrotropic activity 8
  • hCG concentrations >200,000 U/L are associated with TSH <0.2 mU/L in two-thirds of cases 9

Variability Factors: Multiple pregnancy characteristics influence hCG levels 10:

  • Maternal smoking, BMI, parity, and ethnicity
  • Fetal gender
  • Placental weight
  • Presence of hyperemesis gravidarum

Important Caveats:

  • No circadian rhythm exists for hCG—levels remain stable throughout the day, though variations can exceed 10-fold in early pregnancy 11
  • These variations decrease as pregnancy advances 11
  • hCG levels <5 mIU/mL may occur in healthy non-pregnant patients 3
  • Rarely, elevated hCG unrelated to pregnancy occurs with pituitary dysfunction or neoplasia 3

References

Research

Serum human chorionic gonadotropin levels throughout normal pregnancy.

American journal of obstetrics and gynecology, 1976

Research

Human Chorionic Gonadotropin and Early Embryogenesis: Review.

International journal of molecular sciences, 2022

Research

Human chorionic gonadotropin increase in normal early pregnancy.

American journal of obstetrics and gynecology, 1987

Research

Human chorionic gonadotropin as a measure of pregnancy duration.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2013

Guideline

gestational trophoblastic neoplasia, version 2.2019, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2019

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Guideline

graves' disease and pregnancy.

Annales d'endocrinologie, 2018

Research

Daily rhythm of serum human chorionic gonadotropin and human chorionic somatomammotropin in normal pregnancy.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.